Elise Smolders received her Pharmacy Degree (BSc and MSc) at the University of Groningen, Groningen, The Netherlands in 2013. After her graduation she moved to Geneva, Switzerland, for an internship at the World Health Organization, follow by an internship with Health Action International in Amsterdam, the Netherlands. Next, she worked as a pharmacist in the Amphia Hospital in Breda, The Netherlands, focusing on the implementation Epic (hospital information system).
In 2014 she started with her PhD project supervised by prof. dr. David Burger, prof. dr. Joost Drenth, and dr. Klaartje de Kanter at the department of pharmacy of the Radboud university medical center in Nijmegen, the Netherlands. Her research focuses on the clinical pharmacology of ribavirin and the direct-acting antivirals (DAAs) used for a chronic hepatitis C infection. Her thesis will contain chapters about drug-drug interactions with DAAs, therapeutic drug monitoring of ribavirin, and DAA use in special patient populations. Elise will finish her PhD in 2017.
Per 1 March 2017 Elise moved to the Isala hospital in Zwolle, The Netherlands, were she started with her hospital pharmacist training.